A detailed history of Citigroup Inc transactions in Amgen Inc stock. As of the latest transaction made, Citigroup Inc holds 788,509 shares of AMGN stock, worth $249 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
788,509
Previous 686,937 14.79%
Holding current value
$249 Million
Previous $195 Million 26.14%
% of portfolio
0.16%
Previous 0.13%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$262.75 - $319.31 $26.7 Million - $32.4 Million
101,572 Added 14.79%
788,509 $246 Million
Q1 2024

May 10, 2024

BUY
$268.87 - $324.56 $22 Million - $26.6 Million
82,006 Added 13.56%
686,937 $195 Million
Q4 2023

Feb 09, 2024

SELL
$255.7 - $288.46 $2.49 Million - $2.81 Million
-9,750 Reduced 1.59%
604,931 $174 Million
Q3 2023

Nov 09, 2023

SELL
$218.65 - $271.46 $11.5 Million - $14.3 Million
-52,822 Reduced 7.91%
614,681 $165 Million
Q2 2023

Aug 10, 2023

BUY
$214.27 - $253.37 $20.3 Million - $24 Million
94,690 Added 16.53%
667,503 $148 Million
Q1 2023

May 11, 2023

SELL
$225.79 - $275.2 $24.3 Million - $29.6 Million
-107,720 Reduced 15.83%
572,813 $138 Million
Q4 2022

Feb 09, 2023

BUY
$229.03 - $291.01 $28.2 Million - $35.9 Million
123,263 Added 22.12%
680,533 $179 Million
Q3 2022

Nov 10, 2022

BUY
$224.46 - $253.15 $8.36 Million - $9.42 Million
37,226 Added 7.16%
557,270 $126 Million
Q2 2022

Aug 10, 2022

SELL
$230.71 - $256.74 $25.5 Million - $28.3 Million
-110,413 Reduced 17.51%
520,044 $127 Million
Q1 2022

May 12, 2022

SELL
$219.27 - $242.57 $126 Million - $139 Million
-573,846 Reduced 47.65%
630,457 $152 Million
Q4 2021

Feb 10, 2022

BUY
$198.88 - $227.6 $20.8 Million - $23.8 Million
104,738 Added 9.53%
1,204,303 $271 Million
Q3 2021

Nov 10, 2021

BUY
$212.27 - $248.7 $233 Million - $273 Million
1,099,565 New
1,099,565 $234 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.